Yung-Chieh Chang

BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells

Tzu‐Yu Lin, Hsiu-Han Chan, Shang‐Hung Chen et al. · Autophagy · 2019 · 148 citations · Full text

Life Sciences, Cell Biology, Oncology +17

<scp>YM155</scp> down‐regulates survivin and <scp>XIAP</scp>, modulates autophagy and induces autophagy‐dependent <scp>DNA</scp> damage in breast cancer cells

Siao Muk Cheng, Yung-Chieh Chang, C Y Liu et al. · British Journal of Pharmacology · 2014 · 93 citations · Full text

Medicine, Oncology, Pharmacology +17

Malignancy may adversely influence the quality and behaviour of oocytes

Lubna Pal, Lucy Leykin, J. L. Schifren et al. · Human Reproduction · 1998 · 67 citations · Full text

Medicine, Gynecology, Oncology +13

Mutation of the PTCH1 gene predicts recurrence of breast cancer

Chih‐Yang Wang, Yung-Chieh Chang, Yao-Lung Kuo et al. · Scientific Reports · 2019 · 59 citations · Full text

Medicine, Bioinformatics, Oncology +17

The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells

Yung-Chieh Chang, Sree Karani Kondapuram, Tsung-Han Yang et al. · Toxicology and Applied Pharmacology · 2020 · 47 citations

Life Sciences, Molecular Biology, Oncology +9